千葉県全県共用型急性心筋梗塞地域連携パス運用 … · Web...

Click here to load reader

Transcript of 千葉県全県共用型急性心筋梗塞地域連携パス運用 … · Web...

304

28CAMP-S27239853250625.4CAMP-S12000CAMP-SCAMP-S

26CAMP-S29CAMP-S

(TDM)

CAMP-S

304

CAMP-S

214

224

234

22A

244

12

ABC

C1

254

2

CAMP-S25224

CAMP-S

4

264

26

NOAC

PHQ-9

274

22

NOACTM

FIM

HP

284

2015NOACK2

7

ABC

C

BC

ABC

()

A

C

C

SIASStroke Impairment Assessment SetMMTBrunnstrom StageBrunstrom StageStageSIASBrunnstrom Stage

SIAS

90

90

9010

3

SIAS

Functional Independence Measure

2.

PHQ-9PHQ-9

20091Post-Stroke Depression: PSD186223341426PSDADL3.42)PSDADL2)

PHQ-9

PatientHealth QuestionnairePHQ-9

2

1

0

1

2

3

2

0

1

2

3

3

0

1

2

3

4

0

1

2

3

5

0

1

2

3

6

0

1

2

3

7

0

1

2

3

8

0

1

2

3

9

0

1

2

3

1

12

25

PHQ-9

91014151920

PSD

SSRI

10mg0.521

25mg1412

10mg0.541412

25mg1612

(SNRI)

15mg1412

20mg131

NaSSA

15mg0.531

P450CYP2D61A23A42C19QT

SSRISNRINaSSA

2009, pp.150-151, 338-340.

Robinson RG: The Clinical Neuropsychiatry of Stroke 2nd edition Cambridge (MA): Cambridge University Press, 2006.: 2. , , 2013.

1/2

2(3.5cm)

100mg

()

()

4 ()

(TDM)

(PT-INR) TDM ()

()

) AAA

2013

1/32/3

2015ABC1C2D

1 140/90mmHgA130/80mmHg150/90mmHgC1

2 CaACEARBAACEARBBCaB

1 A

2 HMG-CoAA

LDL-AHDL

2014LDLHDL40mg/dLLDL120mg/dLHDL40mg/dLTG150mg/dL

NVAFKNOAC

CHADS221TIA275NOACA1NOACBNOACNOACNOACBNOAC112

PT-INR2.03.0A701.62.6B

NVAF2009NVAFJASTNOAC

ABB

A

450g/1149g/

SAS

SAS

CKD

(CKD)()(A) 130/80mmHg(C1) 2CKD(A)( C1) (ACE)(ARB)(B)CKDNVAFCCr30ml/minNOACB

B

2015

http://www.j-circ.or.jp/guidline

2013

Mark J. Alberts:Using Dabigatran in Patients With Stroke A Practical Guide for Clinicians(Special Report),

Stroke (43) 271-279,2012

CHADS2

CCongestive heart failure1

HHypertension1

AAge751

DDiabetes Millitus 1

SStroke/TIA

2

2013

NOAC

1150mg11110mg

75mg110mg

CC30-50mL/minP-70

P-

15mg11110mg

15mg10mg

CC30-49mL/min10mg11CC15-29L/min10mg11CC15mL/min

Child-PughBC

7550kg

15mg1212.5mg12

5mg2.5mg

8060Kg1.5mg/dlCC

CC15mL/min

60mg130mg1

60mg30mg15mg

60kgCCr50mL/min

CC15mL/min

A200mg/75mg/75150mg/A200mg/BB

12D

ABB

140/90mmHg130/80mmHgB

A

10

1

PDF

A

B

C

C

1C

304030002425

2002 CAMP-SCAMP-SCAMP-SFAX CAMP-S

CAMP-S

()

324CAMP-S

2

7

4-5

CAMP-S

http://www.camp-s.org

261-00123-32-1

TEL:043-279-2211FAX:043-279-2866

[email protected]

275-00264-1-1

047-453-9000(FAX047-453-9002

080-4455-1171

E-mail [email protected]

SIASFIM

2009

2007

Gastroenterol Endsc 2005;47:2691-2695

1

ID

ID

1

11

H10

H20,10,11

BP150HR130

THA

1-

BRST-StageSIAS-

MMT4

MMT3

MMT1or2

VASFaceScale

SO2,

BPHR

3

HDSRMMSE

4-

5-

6-

1

7-

/30

/30

30

0

8-

6060

60

9-

TPO

10

10

10-TUG

TUG

TUG

TUGTimeUpGoTest

11-

12-

1

FIM

ADL

1CS-30

1

2

3

4 510

1

2

3

4

5

2TUG

1

2 303

3

4

5

6

7

1

J

J1:

J2

A

A1:

A2

B

B1:

B2:

C

C1:

C2:

J

J-1

J-2

A

house-bound

A-1

A-2

B

chair-boundB-1B-2

B-1

B-2

C

BBbed-bound

C-1

C-2

2

http://www.maff.go.jp/j/shokusan/seizo/kaigo/jyouhou.html

H

)

)

mm

mm

cm

cm

80kcal3

ml

g

60601400kca

1600kca60

kg

kg

cm

BMI

kg

H

M

T

S

H

)

)

KK

H

M

T

S

kg

kg

cm

BMI

kg

1600kca65

ml

g

kca

mm

mm

cm

cm

H

)

)

H M T S

kg

kg

cm

BM I

kg

1400 kca 55

m l

g

100 100 1400 kca

1501

m m

m m

cm

cm

(

2-2

3

42015/04/01

2-1

H

)

)

H

MTS

kg

kg

cm

BMI

kg

1400kca55

ml

g

1001001400kca

1501

mm

mm

cm

cm

(

2-2

3

4

2015/04/01

2-1

5

DrNSSW

DrNSSW

PTOT

ST

ID

1212345

()

2

60

1m3m5m10m

JJAABBCC

IADL

()

75

50 25

()

()

11

12

m

10TUG

8

9

6

7

/30

4

5

3

1

1)2)3)4)